Adlai Nortye to Present AN0025 Data at ASCO 2024
Ticker: ANL · Form: 6-K · Filed: May 24, 2024 · CIK: 1944552
Sentiment: neutral
Topics: clinical-data, conference-presentation, oncology
TL;DR
Adlai Nortye presenting AN0025 combo data at ASCO 2024, check out their May presentation.
AI Summary
Adlai Nortye Ltd. announced on May 24, 2024, that it will present encouraging data on the combination of its drug AN0025 with definitive chemoradiotherapy (dCRT) at the ASCO 2024 conference. The company also provided a corporate presentation in May 2024. Yang Lu is the CEO and Chairman of the Board.
Why It Matters
The presentation of data at a major oncology conference like ASCO could significantly impact the perceived efficacy and future development of Adlai Nortye's AN0025 drug candidate.
Risk Assessment
Risk Level: medium — The filing indicates a presentation of data, which is a forward-looking event with inherent clinical trial and regulatory risks.
Key Players & Entities
- Adlai Nortye Ltd. (company) — Registrant
- AN0025 (drug) — Drug candidate
- definitive chemoradiotherapy (dCRT) (treatment) — Combination therapy
- ASCO 2024 (conference) — Event for data presentation
- Yang Lu (person) — CEO and Chairman of Board of Directors
FAQ
What specific encouraging data will Adlai Nortye present regarding AN0025 and dCRT at ASCO 2024?
The filing does not specify the exact data points but indicates the presentation will cover 'encouraging data' of the combination therapy.
When is the ASCO 2024 conference scheduled to take place?
The filing does not provide the dates for ASCO 2024, only that Adlai Nortye will present there.
What is the primary purpose of this 6-K filing for Adlai Nortye Ltd.?
This 6-K filing serves as a Report of Foreign Private Issuer, primarily to announce the upcoming presentation of data at ASCO 2024 and to include a corporate presentation.
Where is Adlai Nortye Ltd.'s principal executive office located?
Adlai Nortye Ltd.'s principal executive offices are located at c/o PO Box 309, Ugland House, Grand Cayman, KY1-1104, Cayman Islands.
Who signed this 6-K filing on behalf of Adlai Nortye Ltd.?
Yang Lu, Chief Executive Officer and Chairman of Board of Directors, signed the filing on behalf of Adlai Nortye Ltd.
Filing Stats: 176 words · 1 min read · ~1 pages · Grade level 10.2 · Accepted 2024-05-23 21:42:04
Filing Documents
- tm2415402d1_6k.htm (6-K) — 11KB
- tm2415402d1_ex99-1.htm (EX-99.1) — 12KB
- tm2415402d1_ex99-2.htm (EX-99.2) — 60KB
- tm2415402d1_ex99-2imgg001.jpg (GRAPHIC) — 133KB
- tm2415402d1_ex99-2imgg002.jpg (GRAPHIC) — 440KB
- tm2415402d1_ex99-2imgg003.jpg (GRAPHIC) — 77KB
- tm2415402d1_ex99-2imgg004.jpg (GRAPHIC) — 252KB
- tm2415402d1_ex99-2imgg005.jpg (GRAPHIC) — 188KB
- tm2415402d1_ex99-2imgg006.jpg (GRAPHIC) — 206KB
- tm2415402d1_ex99-2imgg007.jpg (GRAPHIC) — 88KB
- tm2415402d1_ex99-2imgg008.jpg (GRAPHIC) — 183KB
- tm2415402d1_ex99-2imgg009.jpg (GRAPHIC) — 179KB
- tm2415402d1_ex99-2imgg010.jpg (GRAPHIC) — 191KB
- tm2415402d1_ex99-2imgg011.jpg (GRAPHIC) — 209KB
- tm2415402d1_ex99-2imgg012.jpg (GRAPHIC) — 231KB
- tm2415402d1_ex99-2imgg013.jpg (GRAPHIC) — 185KB
- tm2415402d1_ex99-2imgg014.jpg (GRAPHIC) — 272KB
- tm2415402d1_ex99-2imgg015.jpg (GRAPHIC) — 85KB
- tm2415402d1_ex99-2imgg016.jpg (GRAPHIC) — 196KB
- tm2415402d1_ex99-2imgg017.jpg (GRAPHIC) — 203KB
- tm2415402d1_ex99-2imgg018.jpg (GRAPHIC) — 164KB
- tm2415402d1_ex99-2imgg019.jpg (GRAPHIC) — 226KB
- tm2415402d1_ex99-2imgg020.jpg (GRAPHIC) — 224KB
- tm2415402d1_ex99-2imgg021.jpg (GRAPHIC) — 271KB
- tm2415402d1_ex99-2imgg022.jpg (GRAPHIC) — 209KB
- tm2415402d1_ex99-2imgg023.jpg (GRAPHIC) — 221KB
- tm2415402d1_ex99-2imgg024.jpg (GRAPHIC) — 243KB
- tm2415402d1_ex99-2imgg025.jpg (GRAPHIC) — 226KB
- tm2415402d1_ex99-2imgg026.jpg (GRAPHIC) — 217KB
- tm2415402d1_ex99-2imgg027.jpg (GRAPHIC) — 91KB
- tm2415402d1_ex99-2imgg028.jpg (GRAPHIC) — 175KB
- tm2415402d1_ex99-2imgg029.jpg (GRAPHIC) — 155KB
- tm2415402d1_ex99-2imgg030.jpg (GRAPHIC) — 187KB
- tm2415402d1_ex99-2imgg031.jpg (GRAPHIC) — 131KB
- 0001104659-24-064841.txt ( ) — 8433KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Adlai Nortye Ltd. By : /s/ Yang Lu Name : Yang Lu Title : Chief Executive Officer and Chairman of Board of Directors Date: May 23, 2024